A Phase 1a/1b, Multicenter, Open-Label, Dose-Escalation and Dose-Expansion Study to Evaluate the Safety, Pharamcokinetics, and Antitumor Activity of AK119 in Combination with AK104 in Subjects with Advanced or Metastatic Solid Tumors.

  • Markman, Ben (Primary Chief Investigator (PCI))
  • Hawkins, Cheryl-Ann (Project Manager)

Project: Research

Project Details

Effective start/end date24/02/2131/12/26


  • Medical oncology
  • Solid tumours
  • Clinical trial